Abstract
Objective: To evaluate the efficacy of self-administered apomorphine sublingual film (APL-130277; APL) versus placebo for on-demand treatment of “OFF” episodes in patients with Parkinson's disease (PD) based on patient-reported home dosing and response diaries from a pivotal study.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
